Top

Published in:

01-07-2016 | Editorial

Why so many deep brain stimulation targets in Tourette’s syndrome? Toward a broadening of the definition of the syndrome

Authors: M. Porta, C. Saleh, E. Zekaj, C. Zanaboni Dina, A. R. Bona, D. Servello

Published in: Journal of Neural Transmission | Issue 7/2016

Excerpt

Tourette’s syndrome (TS) is a neuro-developmental disorder characterized by simple or complex motor and sound tics starting before age 18 and that last for more than 1 year (TSA definition). TS can be considered as a sensory-sensitive-motor circuit dysfunction along with a strong behavioural component (Zapparoli et al. 2015a, b). It typically affects males more frequently than females (Khalifa and von Knorring 2003). The prevalence of tic disorder is about 0.85–1 % in the adults and up to 20 % in children according to (Robertson 2015). In the whole spectrum 90 % of patients present with at least one co-morbidity, such as obsessive–compulsive disorder (OCD), learning difficulty, poor impulse control, self-injury behaviour (SIB), attention-deficit-hyperactive-disorder (ADHD), non-obscene socially inappropriate behaviour (NOSI) and autistic spectrum disorder (Eapen et al. 2015; Robertson et al. 2015). Coexisting diseases are depression and anxiety symptoms (Robertson 2015). Tics are the main components in childhood, whereas OCD and other psychopathological traits are encountered more frequently in adolescence. …

Ackermans L, Temel Y, Visser-Vandewalle V (2008) Deep brain stimulation in Tourette’s syndrome. Neurother J Am Soc Exp Neurother 5(2):339–344CrossRef

Ackermans L, Duits A, van der Linden C, Tijssen M, Schruers K, Temel Y et al (2011) Double-blind clinical trial of thalamic stimulation in patients with Tourette syndrome. Brain J Neurol 134(Pt 3):832–844CrossRef

Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571CrossRefPubMed

Bruun RD (1988) Subtle and underrecognized side effects of neuroleptic treatment in children with Tourette’s disorder. Am J Psychiatry 145(5):621–624CrossRefPubMed

Cavanna AE, Schrag A, Morley D, Orth M, Robertson MM, Joyce E et al (2008) The Gilles de la Tourette syndrome-quality of life scale (GTS-QOL): development and validation. Neurology 71(18):1410–1416CrossRefPubMed

Cavanna AE, Eddy CM, Mitchell R, Pall H, Mitchell I, Zrinzo L et al (2011) An approach to deep brain stimulation for severe treatment-refractory Tourette syndrome: the UK perspective. Br J Neurosurg 25(1):38–44CrossRefPubMed

Conners CK (1998) Rating scales in attention-deficit/hyperactivity disorder: use in assessment and treatment monitoring. J Clin Psychiatry 59(Suppl 7):24–30PubMed

Eapen V, Robertson MM (2015) Are there distinct subtypes in Tourette syndrome? Pure-Tourette syndrome versus Tourette syndrome-plus, and simple versus complex tics. Neuropsychiatr Dis Treat 11:1431–1436CrossRefPubMedPubMedCentral

Eapen V, Ward P, Clarke R (2014) Clonidine in Tourette syndrome and sensorimotor gating. Psychiatry Res 215(2):494–496CrossRefPubMed

Eapen V, Snedden C, Črnčec R, Pick A, Sachdev P (2015) Tourette syndrome, co-morbidities and quality of life. Aust N. Z. J Psychiatry. pii: 0004867415594429 (Epub ahead of print)

Eddy CM, Rickards HE, Cavanna AE (2011) Treatment strategies for tics in Tourette syndrome. Thera Adv Neurol Disord 4(1):25–45CrossRef

Falowski SM, Sharan A, Reyes BA, Sikkema C, Szot P, Van Bockstaele EJ (2011) An evaluation of neuroplasticity and behavior after deep brain stimulation of the nucleus accumbens in an animal model of depression. Neurosurgery 69(6):1281–1290CrossRefPubMedPubMedCentral

Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR et al (1989a) The Yale-Brown Obsessive Compulsive Scale. II. Validity. Arch Gen Psychiatry 46(11):1012–1016CrossRefPubMed

Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL et al (1989b) The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 46(11):1006–1011CrossRefPubMed

Grados MA, Mathews CA (2008) Tourette Syndrome Association International Consortium for G. Latent class analysis of Gilles de la Tourette syndrome using comorbidities: clinical and genetic implications. Biol Psychiatry 64(3):219–225CrossRefPubMedPubMedCentral

Hariz MI, Robertson MM (2010) Gilles de la Tourette syndrome and deep brain stimulation. Eur J Neurosci 32(7):1128–1134CrossRefPubMed

Hassler R, Dieckmann G (1970) Stereotaxic treatment of tics and inarticulate cries or coprolalia considered as motor obsessional phenomena in Gilles de la Tourette’s disease. Rev Reurol 123(2):89–100

Jankovic J, Kurlan R (2011) Tourette syndrome: evolving concepts. Mov Dis Off J Mov Dis Soc 26(6):1149–1156CrossRef

Kefalopoulou Z, Zrinzo L, Jahanshahi M, Candelario J, Milabo C, Beigi M et al (2015) Bilateral globus pallidus stimulation for severe Tourette’s syndrome: a double-blind, randomised crossover trial. Lancet Neurol 14(6):595–605CrossRefPubMed

Khalifa N, von Knorring AL (2003) Prevalence of tic disorders and Tourette syndrome in a Swedish school population. Dev Med Child Neurol 45(5):315–319CrossRefPubMed

Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J et al (1989) The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 28(4):566–573CrossRefPubMed

Martinez-Torres I, Hariz MI, Zrinzo L, Foltynie T, Limousin P (2009) Improvement of tics after subthalamic nucleus deep brain stimulation. Neurology 72(20):1787–1789CrossRefPubMedPubMedCentral

Mink JW, Walkup J, Frey KA, Como P, Cath D, Delong MR et al (2006) Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome. Mov Dis Off J Mov Dis Soc 21(11):1831–1838CrossRef

Motlagh MG, Smith ME, Landeros-Weisenberger A, Kobets AJ, King RA, Miravite J et al (2013) Lessons learned from open-label deep brain stimulation for Tourette syndrome: eight cases over 7 years. Tremor Other Hyperkinet Mov 3 (NY). pii: tre-03-170-4428-1

Muller-Vahl KR, Cath DC, Cavanna AE, Dehning S, Porta M, Robertson MM et al (2011) European clinical guidelines for Tourette syndrome and other tic disorders. Part IV: Deep brain stimulation. Eur Child Adolesc Psychiatry 20(4):209–217CrossRefPubMed

Peterson BS, Leckman JF (1998) The temporal dynamics of tics in Gilles de la Tourette syndrome. Biol Psychiatry 44(12):1337–1348CrossRefPubMed

Piacentini J, Chang S (2005) Habit reversal training for tic disorders in children and adolescents. Behav Modif 29(6):803–822CrossRefPubMed

Piacentini JC, Chang SW (2006) Behavioral treatments for tic suppression: habit reversal training. Adv Neurol 99:227–233PubMed

Piacentini J, Woods DW, Scahill L, Wilhelm S, Peterson AL, Chang S et al (2010) Behavior therapy for children with Tourette disorder: a randomized controlled trial. JAMA 303(19):1929–1937CrossRefPubMedPubMedCentral

Porta M, Sassi M, Cavallazzi M, Fornari M, Brambilla A, Servello D (2008) Tourette’s syndrome and role of tetrabenazine: review and personal experience. Clin Drug Investig 28(7):443–459CrossRefPubMed

Porta M, Sassi M, Ali F, Cavanna AE, Servello D (2009) Neurosurgical treatment for Gilles de la Tourette syndrome: the Italian perspective. J Psychosom Res 67(6):585–590CrossRefPubMed

Porta M, Sassi M, Menghetti C, Servello D (2011) The need for a proper definition of a “treatment refractoriness” in Tourette syndrome. Front Integr Neurosci 5:22CrossRefPubMedPubMedCentral

Robertson MM (2000) Tourette syndrome, associated conditions and the complexities of treatment. Brain J Neurol 123(Pt 3):425–462CrossRef

Robertson MM (2015) A personal 35 year perspective on Gilles de la Tourette syndrome: prevalence, phenomenology, comorbidities, and coexistent psychopathologies. Lancet Psychiatry 2(1):68–87CrossRefPubMed

Robertson MM, Scull DA, Eapen V, Trimble MR (1996) Risperidone in the treatment of Tourette syndrome: a retrospective case note study. J Psychopharmacol 10(4):317–320CrossRefPubMed

Robertson MM, Cavanna AE, Eapen V (2015) Gilles de la Tourette syndrome and disruptive behavior disorders: prevalence, associations, and explanation of the relationships. J Neuropsychiatr Clin Neurosci 27(1):33–41CrossRef

Roessner V, Plessen KJ, Rothenberger A, Ludolph AG, Rizzo R, Skov L et al (2011) European clinical guidelines for Tourette syndrome and other tic disorders. Part II: Pharmacological treatment. Eur Child Adolesc Psychiatry 20(4):173–196CrossRefPubMedPubMedCentral

Saleh C, Gonzalez V, Cif L, Coubes P (2012) Deep brain stimulation of the globus pallidus internus and Gilles de la Tourette syndrome: toward multiple networks modulation. Surg Neurol Int 3(Suppl 2):S127–S142PubMedPubMedCentral

Schrock LE, Mink JW, Woods DW, Porta M, Servello D, Visser-Vandewalle V et al (2015) Tourette syndrome deep brain stimulation: a review and updated recommendations. Mov Disord 30(4):448–471CrossRefPubMed

Servello D, Zekaj E, Saleh C, Lange N, Porta M (2015) Deep brain stimulation in Tourette syndrome: what does the future hold? A cohort of 48 patients. Neurosurgery (Epub ahead of print)

Spielberger CD, Vagg PR (1984) Psychometric properties of the STAI: a reply to Ramanaiah, Franzen, and Schill. J Pers Assess 48(1):95–97CrossRefPubMed

Steeves T, McKinlay BD, Gorman D, Billinghurst L, Day L, Carroll A et al (2012) Canadian guidelines for the evidence-based treatment of tic disorders: behavioural therapy, deep brain stimulation, and transcranial magnetic stimulation. Can J Psychiatry Rev Can Psychiatr 57(3):144–151CrossRef

Storch EA, Lack CW, Simons LE, Goodman WK, Murphy TK, Geffken GR (2007a) A measure of functional impairment in youth with Tourette’s syndrome. J Pediatr Psychol 32(8):950–959CrossRefPubMed

Storch EA, Merlo LJ, Lack C, Milsom VA, Geffken GR, Goodman WK et al (2007b) Quality of life in youth with Tourette’s syndrome and chronic tic disorder. J Clin Child Adolesc Psychol Off J Soc Clin Child Adolesc Psychol Am Psychol Assoc Div 53 36(2):217–227

Termine C, Selvini C, Rossi G, Balottin U (2013) Emerging treatment strategies in Tourette syndrome: what’s in the pipeline? Int Rev Neurobiol 112:445–480CrossRefPubMed

Tremblay L, Worbe Y, Thobois S, Sgambato-Faure V, Feger J (2015) Selective dysfunction of basal ganglia subterritories: from movement to behavioral disorders. Mov Disord 30(9):1155–1170CrossRefPubMed

Vandewalle V, van der Linden C, Groenewegen HJ, Caemaert J (1999) Stereotactic treatment of Gilles de la Tourette syndrome by high frequency stimulation of thalamus. Lancet 353(9154):724CrossRefPubMed

Visser-Vandewalle V, Temel Y, Boon P, Vreeling F, Colle H, Hoogland G et al (2003) Chronic bilateral thalamic stimulation: a new therapeutic approach in intractable Tourette syndrome. Report of three cases. J Neurosurg 99(6):1094–1100CrossRefPubMed

Wardell K, Kefalopoulou Z, Diczfalusy E, Andersson M, Astrom M, Limousin P et al (2015) Deep brain stimulation of the pallidum internum for Gilles de la Tourette syndrome: a patient-specific model-based simulation study of the electric field. Neuromodul J Int Neuromodul Soc 18(2):90–96CrossRef

Weiden P, Bruun R (1987) Worsening of Tourette’s disorder due to neuroleptic-induced akathisia. Am J Psychiatry 144(4):504–505CrossRefPubMed

Welter ML, Mallet L, Houeto JL, Karachi C, Czernecki V, Cornu P et al (2008) Internal pallidal and thalamic stimulation in patients with Tourette syndrome. Arch Neurol 65(7):952–957CrossRefPubMed

Wilhelm S, Peterson AL, Piacentini J, Woods DW, Deckersbach T, Sukhodolsky DG et al (2012) Randomized trial of behavior therapy for adults with Tourette syndrome. Arch Gen Psychiatry 69(8):795–803CrossRefPubMedPubMedCentral

Woods DW, Miltenberger RG (1995) Habit reversal: a review of applications and variations. J Behav Ther Exp Psychiatry 26(2):123–131CrossRefPubMed

Zapparoli L, Porta M, Gandola M, Invernizzi P, Colajanni V, Servello D, Zerbi A, Banfi G, Paulesu E (2015a) An fMRI investigation of motor control in Gilles de la Tourette Syndrome during imagined and executed movements. Eur J Neurosci. doi:10.1111/ejn.13130 PubMed

Zapparoli L, Porta M, Paulesu E (2015b) The anarchic brain in action: the contribution of task-based fMRI studies to the understanding of Gilles de la Tourette syndrome. Curr Opin Neurol 28(6):604–611CrossRefPubMed

Zekaj E, Saleh C, Porta M, Servello D (2015) Temporary deep brain stimulation in Gilles de la Tourette syndrome: a feasible approach? Surg Neurol Int 6:122CrossRefPubMedPubMedCentral

Title: Why so many deep brain stimulation targets in Tourette’s syndrome? Toward a broadening of the definition of the syndrome
Authors: M. Porta
C. Saleh
E. Zekaj
C. Zanaboni Dina
A. R. Bona
D. Servello
Publication date: 01-07-2016
Publisher: Springer Vienna
Published in: Journal of Neural Transmission / Issue 7/2016
Print ISSN: 0300-9564
Electronic ISSN: 1435-1463
DOI: https://doi.org/10.1007/s00702-015-1494-1

At a glance: The STEP trials

Springer Medicine

Why so many deep brain stimulation targets in Tourette’s syndrome? Toward a broadening of the definition of the syndrome

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 7/2016

Central thalamic deep brain stimulation to support anterior forebrain mesocircuit function in the severely injured brain

Understanding the human pedunculopontine nucleus in Parkinson’s disease

DBS in Tourette syndrome: where are we standing now?

Brainstem control of locomotion and muscle tone with special reference to the role of the mesopontine tegmentum and medullary reticulospinal systems

The primate pedunculopontine nucleus region: towards a dual role in locomotion and waking state

Implications of gamma band activity in the pedunculopontine nucleus